Severe developmental bone phenotype in ClC-7 deficient mice

Developmental Biology

Volumn 344, Issue 2, 2010, Pages 1001-1010

  Neutzsky Wulff, A V ^a   Sims, N A ^b   Supanchart, C ^c,f   Kornak, U ^c,d   Felsenberg, D ^e   Poulton, I J ^b   Martin, T J ^b   Karsdal, M A ^a   Henriksen, K ^a  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Acidification; ClC 7; CLCN7; Endochondral ossification; Osteoclasts; Osteopetrosis

Indexed keywords

CALCEIN; GENE PRODUCT; PROTEIN CIC 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; CARTILAGE; CELL FATE; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOID; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; TRABECULAR BONE;

LACUNA; MUS;

EID: 77955279416     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2010.06.018     Document Type: Article

References (56)

1. Alatalo S.L., Ivaska K.K., Waguespack S.G., Econs M.J., Vaananen H.K., Halleen J.M. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin. Chem. 2004, 50:883-890.
2. Amling M., Neff L., Priemel M., Schilling A.F., Rueger J.M., Baron R. Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. Bone 2000, 27:603-610.
3. Balemans W., Van Wesenbeeck L., Van Hul W. A clinical and molecular overview of the human osteopetroses. Calcif. Tissue Int. 2005, 77:263-274.
4. Baron R. General Principles of Bone Biology 2003, 1-8.
5. Blavier L., Delaisse J.M. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 1995, 108(Pt 12):3649-3659.
6. Bollerslev J., Steiniche T., Melsen F., Mosekilde L. Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types. Bone 1989, 10:19-24.
7. Bollerslev J., Marks S.C., Pockwinse S., Kassem M., Brixen K., Steiniche T., Mosekilde L. Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone 1993, 14:865-869.
8. Boyce B.F., Yoneda T., Lowe C., Soriano P., Mundy G.R. Requirement of pp 60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 1992, 90:1622-1627.
9. Clarke B. Normal bone anatomy and physiology. Clin. J. Am. Soc. Nephrol. 2008, 3(Suppl 3):S131-S139.
10. Cleiren E., Benichou O., Van Hul E., Gram J., Bollerslev J., Singer F.R., Beaverson K., Aledo A., Whyte M.P., Yoneyama T., deVernejoul M.C., Van Hul W. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum. Mol. Genet. 2001, 10:2861-2867.
11. Del Fattore A., Peruzzi B., Rucci N., Recchia I., Cappariello A., Longo M., Fortunati D., Ballanti P., Iacobini M., Luciani M., Devito R., Pinto R., Caniglia M., Lanino E., Messina C., Cesaro S., Letizia C., Bianchini G., Fryssira H., Grabowski P., Shaw N., Bishop N., Hughes D., Kapur R.P., Datta H.K., Taranta A., Fornari R., Migliaccio S., Teti A. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J. Med. Genet. 2006, 43:315-325.
12. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., Delaisse J.M. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 2000, 151:879-889.
13. Everts V., de Vries T.J., Helfrich M.H. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim. Biophys. Acta 2009, 1792:757-765.
14. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P., Keeling D.J., Andersson A.K., Wallbrandt P., Zecca L., Notarangelo L.D., Vezzoni P., Villa A. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 2000, 25:343-346.
15. Frattini A., Pangrazio A., Susani L., Sobacchi C., Mirolo M., Abinun M., Andolina M., Flanagan A., Horwitz E.M., Mihci E., Notarangelo L.D., Ramenghi U., Teti A., Van Hove J., Vujic D., Young T., Albertini A., Orchard P.J., Vezzoni P., Villa A. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 2003, 18:1740-1747.
16. Frische S., Zolotarev A.S., Kim Y.H., Praetorius J., Alper S., Nielsen S., Wall S.M. AE2 isoforms in rat kidney: immunohistochemical localization and regulation in response to chronic NH4Cl loading. Am. J. Physiol. Ren. Physiol. 2004, 286:F1163-F1170.
17. Gil-Henn H., Destaing O., Sims N.A., Aoki K., Alles N., Neff L., Sanjay A., Bruzzaniti A., De C.P., Baron R., Schlessinger J. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. J. Cell Biol. 2007, 178:1053-1064.
18. Grodum E., Gram J., Brixen K., Bollerslev J. Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypes. Bone 1995, 16:431-434.
19. Helfrich M.H. Osteoclast diseases. Microsc. Res. Tech. 2003, 61:514-532.
20. Henriksen K., Gram J., Schaller S., Dahl B.H., Dziegiel M.H., Bollerslev J., Karsdal M.A. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am. J. Pathol. 2004, 164:1537-1545.
21. Henriksen K., Sorensen M.G., Nielsen R.h., Gram J., Schaller S., Dziegiel M.H., Everts V., Bollerslev J., Karsdal M.A. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J. Bone Miner. Res. 2006, 21:58-66.
22. Karsdal M.A., Henriksen K. Osteoclasts control osteoblast activity. BoneKey-Osteovision 2007, 4:19-24.
23. Karsdal M.A., Henriksen K., Sorensen M.G., Gram J., Schaller S., Dziegiel M.H., Heegaard A.M., Christophersen P., Martin T.J., Christiansen C., Bollerslev J. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am. J. Pathol. 2005, 166:467-476.
24. Karsdal M.A., Martin T.J., Bollerslev J., Christiansen C., Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity?. J. Bone Miner. Res. 2007, 22:487-494.
25. Karsdal M.A., Neutzsky-Wulff A.V., Dziegiel M.H., Christiansen C., Henriksen K. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem. Biophys. Res. Commun. 2008, 366:483-488.
26. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., Schmitt A., Poet M., Steinfeld R., Schweizer M., Kornak U., Jentsch T.J. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 2005, 24:1079-1091.
27. Kaste S.C., Kasow K.A., Horwitz E.M. Quantitative bone mineral density assessment in malignant infantile osteopetrosis. Pediatr. Blood Cancer 2007, 48:181-185.
28. Kornak U., Schulz A., Friedrich W., Uhlhaas S., Kremens B., Voit T., Hasan C., Bode U., Jentsch T.J., Kubisch C. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 2000, 9:2059-2063.
29. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., Friedrich W., Delling G., Jentsch T.J. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001, 104:205-215.
30. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol. 2008, 40(1):46-62.
31. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000, 21:115-137.
32. Martin T.J. Hormones in the coupling of bone resorption and formation. Osteoporos. Int. 1993, 3(Suppl 1):121-125.
33. Martin T.J., Rodan G.A. Copling of bone resorption and formation during bone remodeling 2001, Academic Press, Osteoporosis, 361-370 pp.
34. Martin T.J., Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 2005, 11:76-81.
35. Martin T., Gooi J.H., Sims N.A. Molecular mechanisms in coupling of bone formation to resorption. Crit. Rev. Eukaryot. Gene Expr. 2009, 19:73-88.
36. Marzia M., Sims N.A., Voit S., Migliaccio S., Taranta A., Bernardini S., Faraggiana T., Yoneda T., Mundy G.R., Boyce B.F., Baron R., Teti A. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J. Cell Biol. 2000, 151:311-320.
37. Mundy G.R., Chen D., Oyajobi B.O. Bone remodelling. Primer on the metabolic bone diseases and disorders of mineral metabolism 2003, 48-58. Cadmus Professional communications, Washington. M.J. Favus (Ed.).
38. Neutzsky-Wulff A.V., Karsdal M.A., Henriksen K. Characterization of the bone phenotype in ClC-7-deficient mice. Calcif. Tissue Int. 2008, 83:425-437.
39. Nielsen B.S., Sehested M., Kjeldsen L., Borregaard N., Rygaard J., Dano K. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer. Lab. Invest. 1997, 77:345-355.
40. Nielsen R.h., Karsdal M.A., Sorensen M.G., Dziegiel M.H., Henriksen K. Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survival. Biochem. Biophys. Res. Commun. 2007, 360(4):834-839.
41. Ogbureke K.U., Zhao Q., Li Y.P. Human osteopetroses and the osteoclast V-H+-ATPase enzyme system. Front. Biosci. 2005, 10:2940-2954.
42. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 1987, 2:595-610.
43. Pederson L., Ruan M., Westendorf J.J., Khosla S., Oursler M.J. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA 2008, 105:20764-20769.
44. Price J.S., Oyajobi B.O., Russell R.G. The cell biology of bone growth. Eur. J. Clin. Nutr. 1994, 48(Suppl 1):S131-S149.
45. Schenk R.K., Spiro D., Wiener J. Cartilage resorption in the tibial epiphyseal plate of growing rats. J. Cell Biol. 1967, 34:275-291.
46. Schinke T., Schilling A.F., Baranowsky A., Seitz S., Marshall R.P., Linn T., Blaeker M., Huebner A.K., Schulz A., Simon R., Gebauer M., Priemel M., Kornak U., Perkovic S., Barvencik F., Beil F.T., Del F.A., Frattini A., Streichert T., Pueschel K., Villa A., Debatin K.M., Rueger J.M., Teti A., Zustin J., Sauter G., Amling M. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat. Med. 2009, 15:674-681.
47. Segovia-Silvestre T., Neutzsky-Wulff A.V., Sorensen M.G., Christiansen C., Bollerslev J., Karsdal M.A., Henriksen K. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum. Genet. 2009, 124:561-577.
48. Shibata S., Suzuki S., Yamashita Y. An ultrastructural study of cartilage resorption at the site of initial endochondral bone formation in the fetal mouse mandibular condyle. J. Anat. 1997, 191(Pt 1):65-76.
49. Sims N.A., Gooi J.H. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin. Cell Dev. Biol. 2008, 19:444-451.
50. Sims N.A., Clement-Lacroix P., Da P.F., Bouali Y., Binart N., Moriggl R., Goffin V., Coschigano K., Gaillard-Kelly M., Kopchick J., Baron R., Kelly P.A. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 2000, 106:1095-1103.
51. Sims N.A., Jenkins B.J., Nakamura A., Quinn J.M., Li R., Gillespie M.T., Ernst M., Robb L., Martin T.J. Interleukin-11 receptor signaling is required for normal bone remodeling. J. Bone Miner. Res. 2005, 20:1093-1102.
52. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
53. Teti A., Blair H.C., Teitelbaum S.L., Kahn A.J., Koziol C., Konsek J., Zambonin-Zallone A., Schlesinger P.H. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian osteoclasts. J. Clin. Invest. 1989, 83:227-233.
54. Tolar J., Teitelbaum S.L., Orchard P.J. Osteopetrosis. N. Engl. J. Med. 2004, 351:2839-2849.
55. Waguespack S.G., Hui S.L., Dimeglio L.A., Econs M.J. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J. Clin. Endocrinol. Metab. 2007, 92:771-778.
56. Walker E., McGregor N., Poulton I., Pompolo S., Allan E., Quinn J., Gillespie M., Martin T., Sims N.A. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J. Bone Miner. Res. 2008, 23(12):2025-2032.